By: Steve Cimino From: medscape.com A new follow-up study of menopausal hormone therapy found that prior use of conjugated equine estrogen (CEE) decreased both breast cancer incidence and mortality, while prior use of CEE plus medroxyprogesterone acetate (MPA) was associated with an increase in incidence. “Prior use of CEE alone is, to our knowledge, the first pharmacologic intervention demonstrated to …